This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Each year some hundreds of physicians and surgeons gather to learn the latest results and opinions concerning specific drug therapy of tuberculosis as revealed at the Conference on Chemotherapy of Tuberculosis, sponsored by the Veterans Administration and the armed forces. A report to the Council on Pharmacy and Chemistry concerning developments in this field as reported at the 15th conference appears elsewhere in this issue of The Journal (see page 471). This continuing cooperative project, surely the largest in the history of medicine, has involved more than 50 hospitals and at least 15,000 patients. In addition to supplying factual data and a digest of opinions to physicians everywhere, this conference constitutes a powerful educational force within the VA and the armed forces. Never before has it been demonstrated so well that unique research opportunities in the federal services are offered to physicians with a scholarly bent.
The accumulated data convince
Hinshaw HC. FURTHER PROGRESS IN SPECIFIC THERAPY OF TUBERCULOSISGUEST EDITORIAL. JAMA. 1956;162(5):474. doi:10.1001/jama.1956.02970220038010
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: